ARGX Argenx
1,095
$374.63
$7.92
(2.07%)
| Watchers | 1,095 |
| 52-Wk Low | $327.73 |
| 52-Wk High | $550.76 |
| Market Cap | $22.74B |
| Volume | 369,022.00 |
| 52-Wk High | $550.76 |
| 52-Wk Low | $327.73 |
argenx SE (NASDAQ:ARGX) Position Boosted by Raymond James Financial Services Advisors Inc.Zolmax • about 1 month ago
Raymond James Financial Services Advisors Inc. increased its holdings in argenx SE (NASDAQ:ARGX - Free Report) by 30.4% in the fourth quarter, according to its most recent 13F filing with the...
Share to Feed
TimesSquare Capital Management, an equity investment management company, released its U.S. Mid Cap Growth Strategy fourth-quarter investor letter. A copy of the same can be downloaded here. In the...
Leerink Partners analyst Thomas Smith has maintained their bullish stance on ARGX stock, giving a Buy rating on March 27. Thomas Smith has given hi...
Values First Advisors Inc. decreased its holdings in argenx SE (NASDAQ:ARGX Free Report) by 32.6% during the 4th quarter, according to the company in its most recent disclosure with the...
RHO study supports proof-of-concept in primary Sjogren's disease Decision informed by favorable safety profile and consistency across efficacy and biomarker measures March 27, 2024, 7:00 AM CET...
March 26, 2024 Amsterdam, the Netherlands argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases...
VYVGART now approved in Japan for both generalized myasthenia gravis and primary immune thrombocytopenia (ITP) Regulatory decision in Japan represents first global approval for VYVGART in ITP...
Oak Ridge Investments LLC reduced its holdings in argenx SE (NASDAQ:ARGX Free Report) by 6.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange...
This is a Bullish indicator signaling ARGX's price could rise from here. Traders may explore going long the stock or buying call options...
This price move could indicate a change in the trend, and may be a buy signal for investors...